The management of depression: An international naturalistic survey

International Journal of Psychiatry in Clinical Practice

Volumn 12, Issue 4, 2008, Pages 285-291

  Lecrubier, Yves ^a   Bahk, Won Myong ^b   De Matos, José ^c   Briley, Mike ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b The Catholic University of Korea   (South Korea)

^c Hospital Miguel Bombarda   (Portugal)

^d NeuroBiz Consulting and Communication   (France)

Author keywords

Antidepressants; Anxiolytics; Depression management; Naturalistic; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CHILE; DEPRESSION; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; INTERNATIONAL COOPERATION; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NATURALISTIC INQUIRY; PORTUGAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIST; TAIWAN; TREATMENT OUTCOME; TURKEY (REPUBLIC);

EID: 55349088256     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500802108948     Document Type: Article

References (18)

1. Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH. A 40-year perspective on the prevalence of depression. The Stirling County Study. Arch Gen Psychiatry 2000;57:209-15.
2. Druss BG, Hoff RA, Rosenheck RA. Underuse of antidepressants in major depression: prevalence and correlates in a national sample of young adults. J Clin Psychiatry 2000;61:234-7.
3. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61.
4. Katz SJ, Kessler RC, Lin E, Wells KB. Medication management of depression in the United States and Ontario. J Gen Intern Med 1998;13:77-85.
5. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery. Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001;52:1615-20.
6. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. J Am Med Assoc 1997;277:333-40.
7. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 2000;14:3-20.
8. NICE. Depression: management of depression in primary and secondary care - NICE guidance 2004 [http://guidance.nice.org.uk/CG23].
9. APA Practice guideline for the treatment of patients with major depressive disorder. 2nd ed.; 2006 [http://www.psych.org/psych_pract/treatg/pg/ MDD2e_05-15-06.pdf]
10. Lépine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19-29.
11. De Marco RR The epidemiology of major depression: implications of occurrence, recurrence, and stress in a Canadian community sample. Can J Psychiatry 2000;45:67-74.
12. Nelson J, Chouinard G. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology. Can J Clin Pharmacol 1999;6:69-83.
13. Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, et al. World Council of Anxiety (WCA) recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr 2003;8(Suppl 1):53-61.
14. Nemeroff CB, Thase ME, EPIC 014 Study Group. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. J Psychiatr Res 2007;41:351-9.
15. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 2005;66:974-81.
16. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994;48:25-40.
17. Schrader GD, Gibbs A, Harcourt RG. An outpatient survey of antidepressant prescription habits. Aust NZ J Psychiatry 1986;20:487-91.
18. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003;26:457-94.